Spots Global Cancer Trial Database for chimeric antigen receptor (car) t cell therapy
Every month we try and update this database with for chimeric antigen receptor (car) t cell therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors | NCT04650451 | HER-2 Gene Ampl... HER2-positive G... HER2-positive B... HER-2 Protein O... Solid Tumor, Ad... | chimeric antige... | 18 Years - | Bellicum Pharmaceuticals |